Reply to Andréasson et al.: Multiple Manifestations of Systemic Sclerosis Affect Walk Distance

por Zamanian, Roham T., Pinckney, Ashley, Domsic, Robyn T., Medsger, Thomas, Keyes-Elstein, Lynette, Sweatt, Andrew J., Welch, Beverly, Goldmuntz, Ellen, Nicolls, Mark R.
Publicado 2021

Two- and Four-Hour Tests Differ in Capture of C-Peptide Responses to a Mixed Meal in Type 1 Diabetes

por Boyle, Karen D., Keyes-Elstein, Lynette, Ehlers, Mario R., McNamara, James, Rigby, Mark R., Gitelman, Stephen E., Weiner, Lia J., Much, Kristen L., Herold, Kevan C.
Publicado 2016

Teplizumab (Anti-CD3 mAb) Treatment Preserves C-Peptide Responses in Patients With New-Onset Type 1 Diabetes in a Randomized Controlled Trial: Metabolic and Immunologic Features at...

por Herold, Kevan C., Gitelman, Stephen E., Ehlers, Mario R., Gottlieb, Peter A., Greenbaum, Carla J., Hagopian, William, Boyle, Karen D., Keyes-Elstein, Lynette, Aggarwal, Sudeepta, Phippard, Deborah, Sayre, Peter H., McNamara, James, Bluestone, Jeffrey A.
Publicado 2013

Myeloablative autologous haematopoietic stem cell transplantation resets the B cell repertoire to a more naïve state in patients with systemic sclerosis

por Adamska, Julia Z, Zia, Amin, Bloom, Michelle S, Crofford, Leslie J, Furst, Daniel E, Goldmuntz, Ellen, Keyes-Elstein, Lynette, Mayes, Maureen D, McSweeney, Peter, Nash, Richard A, Pinckney, Ashley, Welch, Beverly, Love, Zelda Z, Sullivan, Keith M, Robinson, William
Publicado 2023

Antithymocyte globulin therapy for patients with recent-onset type 1 diabetes: 2 year results of a randomised trial

por Gitelman, Stephen E., Gottlieb, Peter A., Felner, Eric I., Willi, Steven M., Fisher, Lynda K., Moran, Antoinette, Gottschalk, Michael, Moore, Wayne V., Pinckney, Ashley, Keyes-Elstein, Lynette, Harris, Kristina M., Kanaparthi, Sai, Phippard, Deborah, Ding, Linna, Bluestone, Jeffrey A., Ehlers, Mario R.
Publicado 2016

Characterising the autoantibody repertoire in systemic sclerosis following myeloablative haematopoietic stem cell transplantation

por Ayoglu, Burcu, Donato, Michele, Furst, Daniel E, Crofford, Leslie J, Goldmuntz, Ellen, Keyes-Elstein, Lynette, James, Judith, Macwana, Susan, Mayes, Maureen D, McSweeney, Peter, Nash, Richard A, Sullivan, Keith M, Welch, Beverly, Pinckney, Ashley, Mao, Rong, Chung, Lorinda, Khatri, Purvesh, Utz, Paul J
Publicado 2023

IL-6 receptor blockade does not slow β cell loss in new-onset type 1 diabetes

por Greenbaum, Carla J., Serti, Elisavet, Lambert, Katharina, Weiner, Lia J., Kanaparthi, Sai, Lord, Sandra, Gitelman, Stephen E., Wilson, Darrell M., Gaglia, Jason L., Griffin, Kurt J., Russell, William E., Raskin, Philip, Moran, Antoinette, Willi, Steven M., Tsalikian, Eva, DiMeglio, Linda A., Herold, Kevan C., Moore, Wayne V., Goland, Robin, Harris, Mark, Craig, Maria E., Schatz, Desmond A., Baidal, David A., Rodriguez, Henry, Utzschneider, Kristina M., Nel, Hendrik J., Soppe, Carol L., Boyle, Karen D., Cerosaletti, Karen, Keyes-Elstein, Lynette, Long, S. Alice, Thomas, Ranjeny, McNamara, James G., Buckner, Jane H., Sanda, Srinath
Publicado 2021